Neuroscience research at Nottingham includes:
Members of the theme have made significant research progress on the identification of novel therapeutic targets using an integrated in vivo approach.
Substantial funders include the Arthritis Research UK who funded our Centre of Excellence in Arthritis Pain, BBSRC, EU FP7, FRAME and the Wellcome Trust.
Industrial funding and collaborations include Shire Pharmaceuticals, Roche, Lilly, and Pfizer, demonstrating the success of this approach and importance of our work towards drug development.
Pharmacology and biochemistry of G-protein-coupled receptors
Bi-directional communication between neurons and glia in brain physiology
Carbohydrate and lipid metabolism
Energy metabolism in the brain
Physiology and pathophysiology of nociceptive and treatment of pain
Axonal growth and neural cell polarisation
Neuronal signalling in chronic pain
Hypothalamic control of energy metabolism and reproductive maturation
Dr Tracy Farr
Role of 5-hydroxytryptamine in neurological and mental disorders
Neurobiological processes underlying pain
Pharmacology of mephedrone and MDMA
Neuronal networks electrophysiology
Behavioural and cognitive changes underlying psychiatric diseases
Molecular pharmacology of somatostatin and growth hormone on endocrine cells
Resilience to psychiatric disease at the cellular and molecular level
Stroke and Huntington's Disease
University of NottinghamMedical School
Queen's Medical CentreNottingham NG7 2UH
Connect with The University of Nottingham through social media and our blogs.
Campus maps | More contact information | Jobs
Browser does not support script.